What’s In A Name? Hatch And Waxman Stake Claims To Generic Biologics Bill

Sen. Orrin Hatch, R-Utah, and Rep. Henry Waxman, D-Calif., continue to disagree on how to move toward what could be the next major milestone in the generics industry they essentially created in 1984: generic biologics